| Prostate Neuroendocrine Carcinoma studied in …STUDIED_INderived10 of 12show all (up to 200) |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691465Phase 2 · recruiting Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04709276Phase 2 · active not recruiting A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754425Phase 2 · terminated Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped ALIAS · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06062745Phase 1 · recruiting Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT · condition mapped CURATED_BROADER · 12 trials mapped (8 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094842Phase 1 · withdrawn Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (8 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |